Tumor-infiltrating CD8+ T cells were CD44+, mostly with loss of homing receptors CD62L and CCR7 expression, and composed of two main sub-populations CD45RA− and CD45RA+, suggesting a relatively differentiated status. This evidence concerns the gene SELL and neoplasm.